Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Cherian

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Chemotherapy and Pharmacology|February 16, 2013
Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporterChristina Cherian, Sita Kugel Desmoulin, Lei Wang, et al.
Journal of Neurology|September 19, 2021
The phenotypic spectrum of KCNT1: a new family with variable epilepsy syndromes including mild focal epilepsyChristina Cherian, Juan P Appendino, Setareh Ashtiani, et al.
Journal of Medicinal Chemistry|November 22, 2013
Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activityShermaine Mitchell-Ryan, Yiqiang Wang, Sudhir Raghavan, et al.
Molecular Pharmacology|September 24, 2011
Therapeutic targeting of a novel 6-substituted pyrrolo [2,3-d]pyrimidine thienoyl antifolate to human solid tumors based on selective uptake by the proton-coupled folate transporterSita Kugel Desmoulin, Lei Wang, Eric Hales, et al.
Journal of Medicinal Chemistry|January 21, 2010
Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entryLei Wang, Christina Cherian, Sita Kugel Desmoulin, et al.
Molecular Pharmacology|July 6, 2010
Targeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumorsSita Kugel Desmoulin, Yiqiang Wang, Jianmei Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2012
Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporterAlan Menter, Breck Thrash, Christina Cherian, et al.
Journal of Medicinal Chemistry|September 2, 2011
Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits β-glycinamide ribonucleotide formyltransferaseLei Wang, Sita Kugel Desmoulin, Christina Cherian, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypesSiwei Chen, Bassel W Abou-Khalil, Zaid Afawi, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Chemotherapy and Pharmacology|February 16, 2013
Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporterChristina Cherian, Sita Kugel Desmoulin, Lei Wang, et al.
Journal of Neurology|September 19, 2021
The phenotypic spectrum of KCNT1: a new family with variable epilepsy syndromes including mild focal epilepsyChristina Cherian, Juan P Appendino, Setareh Ashtiani, et al.
Journal of Medicinal Chemistry|November 22, 2013
Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activityShermaine Mitchell-Ryan, Yiqiang Wang, Sudhir Raghavan, et al.
Molecular Pharmacology|September 24, 2011
Therapeutic targeting of a novel 6-substituted pyrrolo [2,3-d]pyrimidine thienoyl antifolate to human solid tumors based on selective uptake by the proton-coupled folate transporterSita Kugel Desmoulin, Lei Wang, Eric Hales, et al.
Journal of Medicinal Chemistry|January 21, 2010
Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entryLei Wang, Christina Cherian, Sita Kugel Desmoulin, et al.
Molecular Pharmacology|July 6, 2010
Targeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumorsSita Kugel Desmoulin, Yiqiang Wang, Jianmei Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2012
Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporterAlan Menter, Breck Thrash, Christina Cherian, et al.
Journal of Medicinal Chemistry|September 2, 2011
Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits β-glycinamide ribonucleotide formyltransferaseLei Wang, Sita Kugel Desmoulin, Christina Cherian, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypesSiwei Chen, Bassel W Abou-Khalil, Zaid Afawi, et al.
Pageof 2